Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc.verified

FHTX

Price:

$4.895

Market Cap:

$272.13M

Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-286, a small molecule inhibitor of the enzymatic activity of BRG1 and BRM for the treatment of metastatic uveal melanoma and relapsed and/or refractory acute myeloid leukemia and myelodysplastic syndrome; and FHD-609, a small molecule protein degrader for BRD9 to treat patients with synovial sarcoma. The company is also developing an enzymatic inhibitor...[Read more]

Industry

Biotechnology

IPO Date

2020-10-23

Stock Exchange

NASDAQ

Ticker

FHTX

The Enterprise Value as of December 2024 (TTM) for Foghorn Therapeutics Inc. (FHTX) is 253.52M

According to Foghorn Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 253.52M. This represents a change of -20.22% compared to the average of 317.78M of the last 4 quarters.

Foghorn Therapeutics Inc. (FHTX) Historical Enterprise Value (quarterly & annually)

How has FHTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Foghorn Therapeutics Inc. over the last ten years is 456.72M. The current 253.52M Enterprise Value has changed 5.45% with respect to the historical average. Over the past ten years (40 quarters), FHTX's Enterprise Value was at its highest in in the December 2021 quarter at 802.74M. The Enterprise Value was at its lowest in in the December 2022 quarter at -27585078.32.

Quarterly (TTM)
Annual

Average

456.72M

Median

495.76M

Minimum

-28937657.46

Maximum

807.30M

Foghorn Therapeutics Inc. (FHTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Foghorn Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.26%

Maximum Annual Enterprise Value = 807.30M

Minimum Annual Increase = -913.72%

Minimum Annual Enterprise Value = -28937657.46

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023235.47M-913.72%
2022-28937657.46-103.58%
2021807.30M9.84%
2020734.95M9.89%
2019668.82M107.26%

Foghorn Therapeutics Inc. (FHTX) Average Enterprise Value

How has FHTX Enterprise Value performed in the past?

The current Enterprise Value of Foghorn Therapeutics Inc. (FHTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

337.94M

5-year avg

483.52M

10-year avg

456.72M

Foghorn Therapeutics Inc. (FHTX) Enterprise Value vs. Peers

How is FHTX’s Enterprise Value compared to its peers?

Foghorn Therapeutics Inc.’s Enterprise Value is less than C4 Therapeutics, Inc. (274.98M), greater than Cyteir Therapeutics, Inc. (-20511738.00), greater than Prelude Therapeutics Incorporated (70.58M), greater than Rezolute, Inc. (247.72M), greater than Shattuck Labs, Inc. (12.77M), less than Monte Rosa Therapeutics, Inc. (355.55M), less than Kymera Therapeutics, Inc. (2.63B), less than Nurix Therapeutics, Inc. (1.30B), greater than Molecular Partners AG (107.67M), greater than MediciNova, Inc. (57.98M), greater than Anebulo Pharmaceuticals, Inc. (29.20M), greater than Champions Oncology, Inc. (119.51M), greater than PMV Pharmaceuticals, Inc. (40.27M), less than Stoke Therapeutics, Inc. (453.99M), greater than Century Therapeutics, Inc. (86.28M), less than Edgewise Therapeutics, Inc. (2.79B), less than Mineralys Therapeutics, Inc. (534.79M), less than Cullinan Oncology, Inc. (603.75M),

Build a custom stock screener for Foghorn Therapeutics Inc. (FHTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Foghorn Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Foghorn Therapeutics Inc. (FHTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Foghorn Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Foghorn Therapeutics Inc.'s Enterprise Value?

What is the highest Enterprise Value for Foghorn Therapeutics Inc. (FHTX)?

What is the 3-year average Enterprise Value for Foghorn Therapeutics Inc. (FHTX)?

What is the 5-year average Enterprise Value for Foghorn Therapeutics Inc. (FHTX)?

How does the current Enterprise Value for Foghorn Therapeutics Inc. (FHTX) compare to its historical average?